Hierarchical clustering of PI3K and MAPK pathway proteins in breast cancer intrinsic subtypes

por Kruger, Dinja T., Opdam, Mark, Sanders, Joyce, van der Noort, Vincent, Boven, Epie, Linn, Sabine C.
Publicado 2020

Hierarchical clustering of activated proteins in the PI3K and MAPK pathways in ER-positive, HER2-negative breast cancer with potential therapeutic consequences

por Kruger, Dinja T., Beelen, Karin J., Opdam, Mark, Sanders, Joyce, van der Noort, Vincent, Boven, Epie, Linn, Sabine C.
Publicado 2018

Postlaryngectomy prosthetic voice rehabilitation outcomes in a consecutive cohort of 232 patients over a 13‐year period

por Petersen, Japke F., Lansaat, Liset, Timmermans, Adriana J., van der Noort, Vincent, Hilgers, Frans J. M., van den Brekel, Michiel W. M.
Publicado 2019

IGF‐1R pathway activation as putative biomarker for linsitinib therapy to revert tamoxifen resistance in ER‐positive breast cancer

por Kruger, Dinja T., Alexi, Xanthippi, Opdam, Mark, Schuurman, Karianne, Voorwerk, Leonie, Sanders, Joyce, van der Noort, Vincent, Boven, Epie, Zwart, Wilbert, Linn, Sabine C.
Publicado 2019

PI3K pathway protein analyses in metastatic breast cancer patients receiving standard everolimus and exemestane

por Kruger, Dinja T., Opdam, Mark, van der Noort, Vincent, Sanders, Joyce, Nieuwenhuis, Michiel, de Valk, Bart, Beelen, Karin J., Linn, Sabine C., Boven, Epie
Publicado 2020

Optimizing Survival Predictions of Hypopharynx Cancer: Development of a Clinical Prediction Model

por Arends, Coralie R., Petersen, Japke F., van der Noort, Vincent, Timmermans, Adriana J., Leemans, C. René, de Bree, Remco, van den Brekel, Michiel W.M., Stuiver, Martijn M.
Publicado 2019

Ritonavir-Boosted Exposure of Kinase Inhibitors: an Open Label, Cross-over Pharmacokinetic Proof-of-Concept Trial with Erlotinib

por Boosman, René J., de Gooijer, Cornedine J., Groenland, Stefanie L., Burgers, Jacobus A., Baas, Paul, van der Noort, Vincent, Beijnen, Jos H., Huitema, Alwin D.R., Steeghs, Neeltje
Publicado 2022

Neoadjuvant nivolumab + T-VEC combination therapy for resectable early stage or metastatic (IIIB-IVM1a) melanoma with injectable disease: study protocol of the NIVEC trial

por Rohaan, Maartje W., Stahlie, Emma H. A., Franke, Viola, Zijlker, Lisanne P., Wilgenhof, Sofie, van der Noort, Vincent, van Akkooi, Alexander C. J., Haanen, John B. A. G.
Publicado 2022

Cell-free DNA in the supernatant of pleural effusion can be used to detect driver and resistance mutations, and can guide tyrosine kinase inhibitor treatment decisions

por Hummelink, Karlijn, Muller, Mirte, Linders, Theodora C., van der Noort, Vincent, Nederlof, Petra M., Baas, Paul, Burgers, Sjaak, Smit, Egbert F., Meijer, Gerrit A., van den Heuvel, Michel M., van den Broek, Daan, Monkhorst, Kim
Publicado 2019

[18F]FDG PET/CT-based response assessment of stage IV non-small cell lung cancer treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patches

por de Jong, Evelyn E. C., van Elmpt, Wouter, Leijenaar, Ralph T. H., Hoekstra, Otto S., Groen, Harry J. M., Smit, Egbert F., Boellaard, Ronald, van der Noort, Vincent, Troost, Esther G. C., Lambin, Philippe, Dingemans, Anne-Marie C.
Publicado 2016

Combining variant detection and fragment length analysis improves detection of minimal residual disease in postsurgery circulating tumour DNA of stage II–IIIA NSCLC patients

por Vessies, Daan C. L., Schuurbiers, Milou M. F., van der Noort, Vincent, Schouten, Irene, Linders, Theodora C., Lanfermeijer, Mirthe, Ramkisoensing, Kalpana L., Hartemink, Koen J., Monkhorst, Kim, van den Heuvel, Michel M., van den Broek, Daan
Publicado 2022

The oncological characteristics of non‐prostate‐specific membrane antigen (PSMA)‐expressing primary prostate cancer on preoperative PSMA positron emission tomography/computed tomog...

por Veerman, Hans, Donswijk, Maarten, Bekers, Elise, Bodar, Yves J.L., Meijer, Dennie, van Moorselaar, R. Jeroen A., Oprea‐Lager, Daniela E., van der Noort, Vincent, van Leeuwen, Pim J., Vis, André N., van der Poel, Henk G.
Publicado 2022

Efficacy of Ibandronate Loading Dose on Rapid Pain Relief in Patients With Non-Small Cell Lung Cancer and Cancer Induced Bone Pain: The NVALT-9 Trial

por Brouns, Anita J. W. M., Hendriks, Lizza E. L., van der Noort, Vincent, van de Borne, Ben E. E. M, Schramel, Franz M. N. H., Groen, Harry J. M., Biesma, Bonne, Smit, Hans J. M., Dingemans, Anne-Marie C.
Publicado 2020

FGFR1, 2 and 3 protein overexpression and molecular aberrations of FGFR3 in early stage non‐small cell lung cancer

por Theelen, Willemijn SME, Mittempergher, Lorenza, Willems, Stefan M, Bosma, Astrid J, Peters, Dennis DGC, van der Noort, Vincent, Japenga, Eva J, Peeters, Ton, Koole, Koos, Šuštić, Tonći, Blaauwgeers, JL, van Noesel, Carel J, Bernards, René, van den Heuvel, Michel M
Publicado 2016

Importance of tumour volume and histology in trimodality treatment of patients with Stage IIIA non-small cell lung cancer—results from a retrospective analysis

por Joosten, Pieter J M, Dickhoff, Chris, van der Noort, Vincent, Smeekens, Maarten, Numan, Rachel C, Klomp, Houke M, van Diessen, Judi N A, Belderbos, Jose S A, Smit, Egbert F, Monkhorst, Kim, Oosterhuis, Jan W A, van den Heuvel, Michel M, Dahele, Max, Hartemink, Koen J
Publicado 2021

Sentinel Node Procedure to Select Clinically Localized Prostate Cancer Patients with Occult Nodal Metastases for Whole Pelvis Radiotherapy

por de Barros, Hilda A., Duin, Jan J., Mulder, Daan, van der Noort, Vincent, Noordzij, M. Arjen, Wit, Esther M.K., Pos, Floris J., Vogel, Wouter V., Schaake, Eva E., van Leeuwen, Fijs W.B., van Leeuwen, Pim J., Grivas, Nikolaos, van der Poel, Henk G.
Publicado 2023

Cancer-immune interactions in ER-positive breast cancers: PI3K pathway alterations and tumor-infiltrating lymphocytes

por Sobral-Leite, Marcelo, Salomon, Izhar, Opdam, Mark, Kruger, Dinja T., Beelen, Karin J., van der Noort, Vincent, van Vlierberghe, Ronald L. P., Blok, Erik J., Giardiello, Daniele, Sanders, Joyce, Van de Vijver, Koen, Horlings, Hugo M., Kuppen, Peter J. K., Linn, Sabine C., Schmidt, Marjanka K., Kok, Marleen
Publicado 2019

A prospective observational registry evaluating clinical outcomes of Radium‐223 treatment in a nonstudy population

por Badrising, Sushil K., Louhanepessy, Rebecca D., van der Noort, Vincent, Coenen, Jules L.L.M., Hamberg, Paul, Beeker, Aart, Wagenaar, Nils, Lam, Marnix G.E.H., Celik, Filiz, Loosveld, Olaf J.L., Oostdijk, Ad, Zuetenhorst, Hanneke, Haanen, John B., Vegt, Erik, Zwart, Wilbert, Bergman, Andries M.
Publicado 2020

IHC-based Ki67 as response biomarker to tamoxifen in breast cancer window trials enrolling premenopausal women

por Joosten, Stacey E. P., Wellenstein, Marius, Koornstra, Rutger, van Rossum, Annelot, Sanders, Joyce, van der Noort, Vincent, Ferrandez, Maria C., Harkes, Rolf, Mandjes, Ingrid A. M., Rosing, Hilde, Huitema, Alwin, Beijnen, Jos H., Wesseling, Jelle, van Diest, Paul J., Horlings, Hugo M., Linn, Sabine C., Zwart, Wilbert
Publicado 2021

Immune monitoring in mesothelioma patients identifies novel immune-modulatory functions of gemcitabine associating with clinical response

por Dammeijer, Floris, De Gooijer, Cornedine J., van Gulijk, Mandy, Lukkes, Melanie, Klaase, Larissa, Lievense, Lysanne A., Waasdorp, Cynthia, Jebbink, Merel, Bootsma, Gerben P., Stigt, Jos A., Biesma, Bonne, Kaijen-Lambers, Margaretha E.H., Mankor, Joanne, Vroman, Heleen, Cornelissen, Robin, Baas, Paul, Van der Noort, Vincent, Burgers, Jacobus A., Aerts, Joachim G.
Publicado 2021